The total value of deals for 2019 exceeds $30 billion.
Overall activity in deals jumped 11% in North America.
Industry consolidation, consumerized medical devices and cybersecurity are the top issues in the year ahead.
Medical device companies have upped their game in product security and regulatory compliance, but they might not be ready for a catastrophic event.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.
Olivier Bohuon says he is not a fan of the concept of big is beautiful, and adds that there’s not much innovation occurring in hip implants.